SHA:688091 Revenue

In the year 2025, Shanghai Yizhong Pharmaceutical had annual revenue of 317.08M CNY with 82.72% growth. Shanghai Yizhong Pharmaceutical had revenue of 73.95M in the quarter ending December 31, 2025, with 1,784.30% growth.

Revenue

317.08M

Revenue Growth

+82.72%

P/S Ratio

33.37

Revenue / Employee

845.54K

Employees

415

Market Cap

10.58B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	317.08M	143.54M	82.72%
Dec 31, 2024	173.53M	-186.72M	-51.83%
Dec 31, 2023	360.25M	124.30M	52.68%
Dec 31, 2022	235.96M	231.88M	5,686.75%
Dec 31, 2021	4.08M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Yantai Dongcheng Pharmaceutical Group	2.75B
Tianjin Chase Sun Pharmaceutical Co.,Ltd	5.49B
North China Pharmaceutical Company.Ltd	9.79B
Zhejiang CONBA Pharmaceutical	6.58B
Beijing Foyou Pharma CO.,LTD	3.42B
Jiangsu Yahong Meditech	277.12M
Mayinglong Pharmaceutical Group	3.77B
Porton Pharma Solutions	3.43B

Revenue Rankings